Are we doing enough? Navigating the changing landscape of mHSPC
Janssen sponsored Industry Session at the EAU 2021 Virtual Congress
Agenda
Learning objective:
After watching this broadcast, participants should be able to:
- Understand advances in therapeutic options in mHSPC and their impact on clinical practice
- Re-evaluate current clinical decision making and define best practice approaches to individualised care for patients with mHSPC
Scientific Committee:
- Alicia Morgans (USA)
- Axel Merseburger (Germany)
Faculty:
- Kim Chi (Canada)
- Steven Joniau (Belgium)
- Joe O’Sullivan (UK)
More Info
63 Minutes
EM-62327 - Date of preparation: May 2021